U.S. Medical Affairs Outsourcing Market (By Services: Medical Science Liaisons (MSLs), Medical Writing & Publishing, Medical Monitoring, Medical Information, Others; By Industry: Pharmaceutical, Biopharmaceutical, Medical Devices) - Regional Outlook and Forecast 2024 to 2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: US Medical Affairs Outsourcing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. US Medical Affairs Outsourcing Market, by Services, 2024-2033
8.1.1. Medical Science Liaisons (MSLs)
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Medical Writing & Publishing
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Medical Monitoring
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Medical Information
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2033)
9.1. US Medical Affairs Outsourcing Market, by Industry, 2024-2033
9.1.1. Pharmaceutical
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Biopharmaceutical
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Medical Devices
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Therapeutic Medical devices
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Diagnostic medical devices
9.1.5.1. Market Revenue and Forecast (2021-2033)
10.1. US
10.1.1. Market Revenue and Forecast, by Services (2021-2033)
10.1.2. Market Revenue and Forecast, by Industry (2021-2033)
11.1. Pharmaceutical Product Development, LLC
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. IQVIA Holdings Inc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. SGS SA
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. ZEINCRO Group
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Pfizer Inc
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. The Medical Affairs Company
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. ICON plc
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Ashfield Healthcare Communications
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Syneos Health Inc
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Wuxi Clinical Development, Inc
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample